During the early stage of pancreatic carcinogenesis, Nrf2 exerts a tumor-suppressive role by binding to antioxidant response elements (AREs) and activating its downstream target genes that regulate the cellular antioxidant/detoxification response and immune surveillance [11–13]. Here, NFE2L2 is linked to neoplasm.